Apollon Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Apollon Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,938	Closed	-$371K	–	967
2023 Q1	$371K	Sell	15,938 -9,394	-37%	-$235K	0.02%	617
2022 Q4	$638K	Sell	25,332 -5,228	-17%	-$140K	0.05%	430
2022 Q3	$806K	Sell	30,560 -12,506	-29%	-$386K	0.07%	315
2022 Q2	$1.25M	Sell	43,066 -2,858	-6%	-$85.3K	0.1%	218
2022 Q1	$1.58M	Sell	45,924 -964	-2%	-$34.1K	0.11%	192
2021 Q4	$2.05M	Buy	+46,888	New	+$2.22M	0.15%	150

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IWC

Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Apollon Wealth Management's IDNA Position: Q2 2023 in Review

Apollon Wealth Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2023, closing a stake of 15,938 shares — an estimated $371K sold.

Apollon Wealth Management first reported a position in IDNA in Q4 2021 and held it in 6 quarters. The position peaked at $2.05M in Q4 2021. 67 funds tracked by Wall St. Rank hold IDNA as of Q2 2023.

Apollon Wealth Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2023 after selling out during the quarter.
Apollon Wealth Management sold 15,938 iShares Genomics Immunology and Healthcare ETF shares in Q2 2023, an estimated $371K.
Apollon Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and held it in 6 quarters.
Apollon Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $2.05M in Q4 2021.
67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2023.

Based on Apollon Wealth Management's 13F filing for Q2 2023, filed 4 Aug 2023.